Global Trial for Blood-Based Hematology Diagnostics to Launch
Three-year PERIBLOOD study will evaluate single-cell RNA sequencing as minimally invasive alternative to bone marrow aspiration for blood disorder diagnosis.
Read More
Search Results for: Indica lab
Barrett’s Esophagus Test Identifies High-Risk Patients Missed by Standard Pathology
A study of 85 patients shows the TissueCypher test detected 15% with elevated cancer progression risk despite a non-dysplastic diagnosis.
Read More
Roche Gains CE IVDR Approval for Expanded HER2 Companion Diagnostic
VENTANA HER2 (4B5) test is now CE-IVDR approved to identify HER2-ultralow breast cancer and HER2-positive biliary tract cancer patients.
Read More
Quest Diagnostics Launches Pharmacogenomics Testing Service for Medication Guidance
New offering combines genetic testing with clinical decision support tools to help optimize medication selection and dosing across multiple specialties.
Read More
Mercy BioAnalytics Raises $59 Million Series B to Advance Cancer Detection Platform
The funding will support commercialization of the company’s extracellular vesicle-based liquid biopsy tests, starting with ovarian cancer screening.
Read More